LivaNova
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LivaNova and other ETFs, options, and stocks.About LIVN
LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS).
CEOVladimir A. Makatsaria
CEOVladimir A. Makatsaria
Employees2,900
Employees2,900
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2015
Founded2015
Employees2,900
Employees2,900
LIVN Key Statistics
Market cap2.91B
Market cap2.91B
Price-Earnings ratio-13.16
Price-Earnings ratio-13.16
Dividend yield—
Dividend yield—
Average volume615.73K
Average volume615.73K
High today$53.50
High today$53.50
Low today$51.56
Low today$51.56
Open price$51.56
Open price$51.56
Volume462.22K
Volume462.22K
52 Week high$58.91
52 Week high$58.91
52 Week low$32.48
52 Week low$32.48
LIVN News
Simply Wall St 8h
LivaNova: Evaluating Current Valuation as Investors Weigh Recent Share Price TrendsLivaNova (LIVN) shares have shown some movement recently, catching investors’ attention after a moderate change in trading activity. With the company posting mi...
TipRanks 2d
LivaNova downgraded to Neutral from Buy at Goldman SachsGoldman Sachs downgraded LivaNova (LIVN) to Neutral from Buy with a price target of $55, down from $56. The firm believes that as the Essenz product cycle passe...
Simply Wall St 6d
Those who invested in LivaNova five years ago are up 15%The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up more than the market average. Unfortunatel...
Analyst ratings
64%
of 11 ratingsBuy
63.6%
Hold
36.4%
Sell
0%
People also own
Based on the portfolios of people who own LIVN. This list is generated using Robinhood data, and it’s not a recommendation.